Two-Pronged attack: weight loss drug and IUD team up to save uteruses
NCT ID NCT05829460
Summary
This study aimed to see if adding a weight loss medication (semaglutide) to a standard hormonal IUD treatment works better than the IUD alone for premenopausal women with obesity and a condition called endometrial hyperplasia (abnormal uterine lining). The goal was to help these women keep their uterus, lose weight, and improve their quality of life. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.